Member Info for andinio

Moniman, they ALL want to invest ;)
Now or later, price will climb thaks to them and others.

No CEO or ex Chairman of AIM listed Co working towards profitability would ever rule out a fund raise.
Your 'basis' is flawed at the outset.

https://quotientbd.com/news/quotient-ceo-franz-walt-talkradio-mike-graham

Jarv55
Good find. thanks
Well worth investors taking a listen

https://www.openorphan.com/covid-19
Covid-19

In the face of this global pandemic, Open Orphan is committed to playing a key role in supporting the development of vaccines and antiviral treatments for COVID-19. Open Orphan is supporting the fight against COVID-19 by mobilizing its in-house capabilities and clinical trials expertise to address the Coronavirus pandemic. The Company is doing so by exploring numerous avenues of research and testing as enumerated below.

Correct, as Cathal said, he's sees the lab as being a revenue generator in its own right as opposed to being a support function for the revenue generating QU.
He's untapping the resource (anti viral testing and antibody testing being the case)

IMO - By year end a conservative calc would be a market cap of 130 to 150 with further growth and major pipeline for 2021.
In addition, potential for share for share in Imutex vehicle.

If you listen to interview after interview you hear his emphasis towards EXIT reduce and his comments regarding trading next year increase.
Given the covid19 pandemic i expect the pivot point for exit will run into 2021.
IMO - Orph has much more potential in capital growth than 3x (not to mention value from 1 for 1 share in Imutex vehicle)
Right now, Cathal wants all PIs to be winners. He wants you to be investors next time. He doesn't want a BIDSTACK moment or anything like it. He knows where the share price is going but he hoping that everyone wins in some form of orderly fashion. Personally i think he should focus on the business and leave the markets to the markets, but that's how he rolls.

It's a disclaimer comment he makes often. He said same at 5.6 and 6.2 and during placing.

No, he wants to invest but doesn't like the current price.

A major part of business achieved 85 percent occupancy in 1st qtr.

He didn't 'admit' anything.
He 'said' so weeks ago.
Your play on words is obvious misdirection.
Once again, thanks for reminding everyone Open Orphan has key revenue generation potential and was full for 85 percent of 1st qtr ;)

Thanks Fairview for reminding everyone that the clinic is a major revenue generator and was fully occupied Jan through to mid March - unlike previous years when O-rate was low..
Lab was open, and QC back online this week.

Sportstrader, yes....
CF has a track record of informing and 'taking' investors with him. He's not about to ambush PIs with a placing from stage left.
History and good conduct are on his side in this matter.

~laughing~
even if you accept fairview's miserable analysis you still end up with potential for 'additional' 15+ million pound turnover each yr

Yep, CF is about to demonstrate his professional skillset with regards to Imutex.
Watch this space.

They did sell their gran. That's why they hang around here.

Quotient said it has 12 screening machines available which can process up to 36,000 tests a day or 252,000 a week.

A further 20 are expected to be ready by the end of the year.

stepped moves upwards, daily.

Kits available for £99
Order kit. Take a blood sample. Return kit to hVIVO. Receive result for antibody.

https://quotientbd.com/covid-19